**Core Concept**
The treatment of choice for complicated Plasmodium falciparum malaria involves administering an effective antimalarial drug that can rapidly reduce parasite loads and prevent further complications. This requires a drug with potent activity against the parasite, particularly against the ring forms, as well as a favorable safety profile.

**Why the Correct Answer is Right**
Artemisinin-based combination therapies (ACTs) are the recommended treatment for complicated P. falciparum malaria. This is because artemisinin and its derivatives have rapid parasite clearance rates, which are critical in preventing further complications and reducing mortality. The combination of artemisinin with another antimalarial drug, such as lumefantrine (in the case of Coartem), helps to prevent the development of resistance and ensures a sustained reduction in parasite loads.

**Why Each Wrong Option is Incorrect**
**Option A:** Chloroquine is no longer an effective treatment for P. falciparum malaria due to widespread resistance.
**Option B:** Quinine can be used for the treatment of P. falciparum, but it is not the preferred choice for complicated malaria due to its slower parasite clearance rates and higher toxicity.
**Option C:** Sulfadoxine-pyrimethamine (SP) is an effective antimalarial drug, but it is generally reserved for the treatment of uncomplicated malaria or as part of a combination therapy.

**Clinical Pearl / High-Yield Fact**
Artemisinin-based combination therapies are the cornerstone of treatment for complicated P. falciparum malaria, and their use has significantly reduced malaria-related mortality rates in endemic regions.

**Correct Answer:** C. Sulfadoxine-pyrimethamine